Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
EurekAlert!13h
Promising ‘first’ in Alzheimer’s drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
Researchers make breakthrough in Alzheimer's disease drug development
An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.
Neuroscience News11h
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
New study is a promising ‘first’ in Alzheimer’s drug development
Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...
Breakthrough Alzheimer’s drug successfully blocks both major disease ‘hotspots’ at once for the first time
RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...
Staffordshire University20h
Data project benefits HE sector understanding
Researchers have welcomed new resources to help universities make better use of data when evaluating student support ...
Les Miles moves lawsuit over vacated LSU wins from federal to state court
Former football coach Les Miles’ lawsuit against LSU and the NCAA over a decision to vacate 37 of his teams’ victories from ...